What We Do

3 Axis Advisors brings unique approaches to address the individual needs of each or our clients. As researchers and investigators at heart, 3 Axis endeavors are laser-focused on discovery through data-driven analysis and deep industry expertise, resulting in innovative and unique solutions.

Our obsessive passion for understanding complex systems and our immersion in the prescription drug supply chain and the broader healthcare delivery system enables us to arm our clients with the tools they need to accomplish their goals.

In addition to our consulting work, the 3 Axis team also dedicates significant time and resources to power 46brooklyn Research, an Ohio non-profit corporation whose purpose is to improve the accessibility and usability of U.S. drug pricing data.

Born and raised in pharmacy, Antonio has been crawling around pharmacies his entire life.  After three years as a pharmacy technician and two years of pre-pharmacy curriculum, Antonio diverted course, graduating from The Ohio State University in 2007 with dual degrees in communications and political science before moving into the world of association management.

Thinking that pharmacy would be in his rear-view mirror forever, he ended up making his way back to his pharmacy home, heading up government affairs for the Ohio Pharmacists Association, a trade organization with a strong track record of advocating for drug pricing transparency. After years of studying the pharmacy marketplace, Antonio became increasingly perplexed and concerned as he saw drug costs spiking while payouts to pharmacies were declining.

Knowing something was being lost somewhere in the middle of an ever-growing transaction, Antonio has spent years working to crack the drug pricing code and pull the rug out from what he believes is one of the most dysfunctional marketplaces in the world.

Ben has wanted to be a pharmacist since he was in 7th grade. Over the course of his 15+ year career in pharmacy, Ben has experienced the practice from the point of view of a patient, pharmacy technician, intern, pharmacist, assistant pharmacy manager, clinical pharmacist and clinical account manager. Ben has worked with small and mid-sized employer groups, professional organizations, Medicaid programs, workers’ compensation insurers and re-insurers, and Third Party Administrators (TPAs).

While employed within pharmacy benefit managers (PBMs) Ben recognized a need for change within the pharmacy supply chain. Ben joined 3 Axis Advisors to connect pharmacy claims data to people equally committed to getting the healthcare transaction right. Ben’s knowledge include data analysis, database management, clinical evidence evaluation, healthcare policy and project management.

Ben received his degree as a Doctor of Pharmacy from Ohio Northern University with a minor in Spanish Language.

Behind the name

3 Axis Advisors was originally founded in Dayton, Ohio. Our origin city and home state is known for many things, including being the birthplace of the famed Wright brothers. As many know, the Wright brothers are credited for creating and flying the first ever airplane.

While the Wright brothers are widely known for their successes, the self-taught engineers labored extensively through the trial-and-error process before accomplishing what couldn’t be done by others before them. This included a number of failed attempts at flight. But by learning from those challenges, collaborating with others, and pushing against headwinds, Wilbur and Orville Wright were finally successful at rising to new heights.

On March 23, 1903, the brothers filed a patent application for what was dubbed as a “Flying Machine,” which legally documented the theory and application of the 3-axis flight control system that inevitably took them to the skies.

Their innovations were instrumental in driving revolutionary change in human accessibility to the rest of the world.

Driving change

The Wright brothers were not overnight success stories. It took years of studying what came before them, building upon those prior milestones of progress, and understanding the complexity and challenges associated with success and achievement of their goals. It also took understanding failure – a necessary part of the quest for truth.

As we assess our own paths into the bowels of the prescription drug supply chain and the U.S. healthcare system broadly, we see similar journeys – minus the whole flying part.

The way we pay for pharmaceuticals is unnecessarily complex, inefficient, and wasteful. And with increased complexity and industry consolidation, we as consumers – the real payers of healthcare – are stuck and grounded to an insufficient, undeserved, and expensive status quo.

Through greater transparency, simplification, and understanding of our drug channel’s incentive designs, we believe we can drive positive change (Δ) and build a better healthcare delivery system.